Analyzing Revolutions Medical (OTCMKTS:RMCP) and INVO Fertility (NASDAQ:IVF)

INVO Fertility (NASDAQ:IVF) and Revolutions Medical (OTCMKTS:RMCP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings.

Risk and Volatility

INVO Fertility has a beta of 2.66, meaning that its share price is 166% more volatile than the S&P 500. Comparatively, Revolutions Medical has a beta of -0.43, meaning that its share price is 143% less volatile than the S&P 500.

Valuation and Earnings

This table compares INVO Fertility and Revolutions Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53 million	0.96	-$9.10 million	($630.29)	0.00
Revolutions Medical	N/A	N/A	N/A	N/A	N/A

Revolutions Medical has lower revenue, but higher earnings than INVO Fertility.

Institutional and Insider Ownership

12.0% of INVO Fertility shares are held by institutional investors. 0.7% of INVO Fertility shares are held by insiders. Comparatively, 10.5% of Revolutions Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares INVO Fertility and Revolutions Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Revolutions Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current recommendations and price targets for INVO Fertility and Revolutions Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	1	2.50
Revolutions Medical	0	0	0	0	0.00

INVO Fertility currently has a consensus price target of $4.00, suggesting a potential upside of 344.44%. Given INVO Fertility’s stronger consensus rating and higher probable upside, research analysts clearly believe INVO Fertility is more favorable than Revolutions Medical.

Summary

INVO Fertility beats Revolutions Medical on 6 of the 9 factors compared between the two stocks.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Revolutions Medical

Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.